Showing results (31-40 of 131) with videos related to
Sort By:
Pageof 14
Angiogenesis|March 20, 2012
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumorsMaddalena Arigoni, Giuseppina Barutello, Stefania Lanzardo, et al.The Journal of Experimental Medicine|October 18, 2006
Triggering CD40 on endothelial cells contributes to tumor growthClaudia Chiodoni, Manuela Iezzi, Cristiana Guiducci, et al.Iscience|February 26, 2025
Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumorsGiorgia Anastasio, Michela Felaco, Alessia Lamolinara, et al.Cancers|July 29, 2023
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 AntibodyEmanuela Guerra, Marco Trerotola, Valeria Relli, et al.Molecular Cancer Research : MCR|September 13, 2013
HER-2/neu mediates oncogenic transformation via altered CREB expression and functionAndré Steven, Sandra Leisz, Chiara Massa, et al.Cancer Research|June 5, 2003
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant micePatrizia Nanni, Giordano Nicoletti, Carla De Giovanni, et al.BMC Cancer|August 1, 2019
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypesRossano Lattanzio, Manuela Iezzi, Gianluca Sala, et al.Cancer Prevention Research (Philadelphia, Pa.)|August 19, 2010
A dietary tomato supplement prevents prostate cancer in TRAMP miceTania Pannellini, Manuela Iezzi, Marcella Liberatore, et al.Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
AvidinOX for highly efficient tissue-pretargeted radionuclide therapyRita De Santis, Barbara Leoni, Antonio Rosi, et al.Molecular Neurobiology|December 5, 2025
Systematic Phenotyping and Molecular Analysis of the Woozy Mouse: A Preclinical Model of Cerebellar AtaxiaFabio Bellia, Laura Amodei, Anna Giulia Ruggieri, et al.Pageof 14